Acetylcholinesterase inhibitors, including donepezil, galantamine, and rivastigmine, enhance cognitive function in mild to moderate AD patients by increasing acetylcholine levels in the brain through cholinesterase inhibition (Sutton et al., 2024). Here, ACHE is linked to Alzheimer disease.